Ginsenoside Rh2 extract and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- TIANJIN TASLY PHARMA CO LTD
- Publication Date
- 2013-10-02
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a traditional Chinese medicine extract and its preparation, in particular to a ginsenoside Rh2 extract and its preparation. Background technique
[0002] Ginseng has many reports in the treatment of cardiovascular and cerebrovascular diseases.
[0003] Ginseng glycosides can treat coronary heart disease and ischemic stroke.
[0004] Ginsenoside Rh2 is a secondary saponin produced by hydrolysis of ginsenosides. Pharmacodynamic studies have shown that ginsenoside Rh2 has a significant and specific inhibitory effect on the proliferation of cancer cells such as liver cancer, melanoma B16, cervical cancer and sarcoma S180. Its mechanism of action is as follows: in the process of cancer cell proliferation, through the action of ginsenoside Rh2, the cancer cells stop at a certain proliferation stage and promote their reversion to normal cells.
[0005] The effect of prior art separation of ginsenoside Rh2 is not good, and the presen...